Therefore, it can be hypothesized that the synergistic fusion of molecular pathways in TSA may contribute to the relatively rapid and frequent progression of low-grade dysplasia to high-grade dysplasia and carcinoma and may ultimately underlie the age difference between patients with MLH1-methyated and MLH1-unmethylated CIMP-H CRCs. Here, MLH1 is linked to carcinoma.